CCL22 and neoplasm: Specifically, SOX12 transactivated CCL22, which resulted in the accumulation and enhanced activity of CCR4+Tregs within the tumor, whereas SOX18 up‐regulated CXCL12 expression, attracting CXCR4+TAMs and CXCR4+Tregs into the tumor.